Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients
about
Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Serological immune response ag ...... III colorectal cancer patients
@ast
Serological immune response ag ...... III colorectal cancer patients
@en
type
label
Serological immune response ag ...... III colorectal cancer patients
@ast
Serological immune response ag ...... III colorectal cancer patients
@en
prefLabel
Serological immune response ag ...... III colorectal cancer patients
@ast
Serological immune response ag ...... III colorectal cancer patients
@en
P2093
P2860
P50
P356
P1433
P1476
Serological immune response ag ...... III colorectal cancer patients
@en
P2093
Anna Innocenzi
Antonio Conti
Francesca Sanvito
Luca Cannizzaro
Marco Barbariga
Marco Braga
Sheila María Álvarez-Fernández
P2860
P304
80059-80076
P356
10.18632/ONCOTARGET.11181
P407
P577
2016-11-01T00:00:00Z